2001
DOI: 10.1093/ajhp/58.1.63
|View full text |Cite
|
Sign up to set email alerts
|

The Institute of Medicine report on medical error: Overview and implications for pharmacy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
23
0
7

Year Published

2006
2006
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(30 citation statements)
references
References 0 publications
0
23
0
7
Order By: Relevance
“…Several international studies have assessed MEs prevalence in the ICU, and results vary widely [6][7][8][9], mainly due to differences in methodology, ME definitions, and reporting [8]. Recently, a multinational study reported a 33% of MEs prevalence over parenteral drug administration using voluntary reporting [7].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Several international studies have assessed MEs prevalence in the ICU, and results vary widely [6][7][8][9], mainly due to differences in methodology, ME definitions, and reporting [8]. Recently, a multinational study reported a 33% of MEs prevalence over parenteral drug administration using voluntary reporting [7].…”
Section: Introductionmentioning
confidence: 99%
“…Availability of ME-related information enables the assessment of processes more prone for generating errors [9,10]. Only a few studies conducted in Latin American countries allow the identification of part of the processes and causes most responsible for errors.…”
Section: Introductionmentioning
confidence: 99%
“…In the last few years, medication errors have been reported to have caused significant patient harm in many different countries. In the USA, it is estimated that 1-2% of hospital admissions resulted from medication errors [2][3][4]. In Spain, medication errors are responsible for 4.7% of admissions to health services, with an average cost of EUR3,000 per patient [5].…”
Section: Introductionmentioning
confidence: 99%
“…A multidisciplinary approach, including clinical pharmacists addressing DRPs, has been shown to reduce the frequency of DRPs [3][4][5][6][7]. By applying clinical pharmacy services economical savings, reduction of adverse drug events and enhanced quality of life have been reported [8][9][10].…”
Section: Introductionmentioning
confidence: 99%